Aquestive Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Warren, NJ USA
Total Funding:$199.6M
Lead Investor(s):BMO Capital Markets, RBC Capital Markets

Estimated Revenue & Financials

  • Aquestive Therapeutics's estimated annual revenue is currently $6.7M per year.(?)
  • Aquestive Therapeutics received $73.9M in venture funding in August 2018.
  • Aquestive Therapeutics's estimated revenue per employee is $48,489
  • Aquestive Therapeutics's total funding is $199.6M.

Employee Data

  • Aquestive Therapeutics has 139 Employees.(?)
  • Aquestive Therapeutics grew their employee count by -5% last year.
  • Aquestive Therapeutics currently has 1 job openings.

Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people's lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.